TrialEuropean journal of cancer (Oxford, England : 1990)2021

Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.

Youn H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.